Atlas Trials

Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies

Clinical trial NCT02129101 · COMPLETED

Trial details

NCT number
NCT02129101
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromeEssential ThrombocythemiaMyelodysplastic SyndromeMyelodysplastic/Myeloproliferative NeoplasmPolycythemia VeraPreviously Treated Myelodysplastic SyndromePrimary MyelofibrosisRecurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia
Start date
2014-05-01
Primary completion
2016-12-31
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.